BAJAJHCARENSEBajaj Healthcare Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 23 Jun, 2026 · 18:31 IST

Bajaj Healthcare to sell Tarapur unit for up to 4.05 Cr

BAJAJHCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.2%Reaction day
₹313.65
prior close
₹316.20
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-1.1% vs market
Pharmaceuticals peers, median of 164sector-0.0%-1.1% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.6
10m
+1.5
15m
+0.7
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.2-0.1-1.1-0.0-1.1
Next day
-2.5-0.7-1.8-0.8-1.7
2d
+12.7-1.0+13.7+0.0+12.7
3d
+11.7+0.0+11.6+0.3+11.4
4d
+10.0+0.2+9.8+0.2+9.8
5d
+10.0+1.1+8.9+0.3+9.7
1w
+7.7+0.9+6.8+0.6+7.1
15d
+19.2+0.8+18.4+1.1+18.0
1m
+3.4-0.8+4.2-0.6+4.0
2m
+2.6+5.0-2.5+1.4+1.2
3m
+11.0+5.0+6.0+4.9+6.1
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bajaj Healthcare board approved sale of its operational business unit at MIDC Tarapur, Boisar to M/s Orchem Products for up to 4.05 Crores. The unit contributed 3.31 Crores revenue (0.54 percent) and 3.97 Crores net worth (0.74 percent) last year. Not a related party transaction. Expected to close by October 31, 2026.

Likely market impact

Minor divestment, only 0.54 percent of revenue. Unlikely to materially impact stock price or operations.